{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:03:51Z","timestamp":1783469031098,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Institut Pasteur du Maroc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.jp","idhjournal.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Disease & Health"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.idh.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T08:24:35Z","timestamp":1543652675000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chlamydia pneumoniae sero-prevalence in Moroccan patients with cardiovascular diseases"],"prefix":"10.1016","volume":"24","author":[{"given":"Fouzia","family":"Radouani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loubna","family":"El Yazouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"Elyazghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Hejaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz Aroussi","family":"Alami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naima","family":"Elmdaghri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.idh.2018.10.004_bib1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1086\/511076","article-title":"Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods","volume":"44","author":"Kumar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idh.2018.10.004_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1183\/09031936.00.16510010","article-title":"Chlamydia pneumoniae and the lung","volume":"16","author":"Hammerschlag","year":"2000","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.idh.2018.10.004_bib3","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1161\/01.ATV.19.11.2680","article-title":"Chlamydia pneumoniae in abdominal aortic anevrysms: abundance of membrane components in the absence of heat shock protein 60 and DNA","volume":"19","author":"Meijer","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.idh.2018.10.004_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftx039","article-title":"Molecular characterisation of Chlamydia pneumoniae associated to atherosclerosis","volume":"75","author":"El Yazouli","year":"2017","journal-title":"Pathog Dis"},{"key":"10.1016\/j.idh.2018.10.004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/378658","article-title":"Chlamydia pneumoniae mediated inflammation in atherosclerosis: a meta-analysis","volume":"2015","author":"Filardo","year":"2015","journal-title":"Mediat Inflamm"},{"issue":"2","key":"10.1016\/j.idh.2018.10.004_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.atherosclerosis.2014.01.023","article-title":"Association between Chlamydophila pneumoniae infection and risk of coronary heart disease for Japanese: the JPHC study","volume":"233","author":"Sakurai-Komada","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.idh.2018.10.004_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s15010-014-0694-1","article-title":"Influence of intimal Chlamydophila pneumoniae persistence on cardiovascular complications after coronary intervention","volume":"43","author":"Tuleta","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.idh.2018.10.004_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/00313029800169166","article-title":"Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients","volume":"30","author":"Paterson","year":"1998","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.idh.2018.10.004_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jiph.2017.07.029","article-title":"Investigation of Chlamydia pneumoniae infection in Moroccan patients suffering from cardiovascular diseases","volume":"11","author":"El Yazouli","year":"2018","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.idh.2018.10.004_bib10","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/jcm.31.8.2212-2214.1993","article-title":"Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques","volume":"31","author":"Puolakkainen","year":"1993","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idh.2018.10.004_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/514095","article-title":"Antigen conformation-dependence of Chlamydia trachomatis infectivity neutralization","volume":"176","author":"Fan","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idh.2018.10.004_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/jcm.1.3.250-255.1975","article-title":"Simplified immunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody","volume":"1","author":"Wang","year":"1975","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idh.2018.10.004_bib13","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1128\/IAI.69.5.3082-3091.2001","article-title":"Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily detected against conformation-dependent determinants","volume":"69","author":"Wolf","year":"2001","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.idh.2018.10.004_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2958.1993.tb01168.x","article-title":"Chlamydia trachomatis Mip-like protein has peptidyl-prolylcis\/trans isomerase activity that is inhibited by FK 506 and rapamycin and is implicated in initiation of chlamydial infection","volume":"7","author":"Lundemose","year":"1993","journal-title":"Mol Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.idh.2018.10.004_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1155\/S1064744999000137","article-title":"Chlamydial heat shock proteins and disease pathology: new paradigms for old problems?","volume":"7","author":"LaVerda","year":"1999","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.idh.2018.10.004_bib16","first-page":"66","article-title":"Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease","volume":"9","author":"Ciervo","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.idh.2018.10.004_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/IAI.67.1.375-383.1999","article-title":"Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae","volume":"67","author":"Knudsen","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.idh.2018.10.004_bib18","first-page":"179","article-title":"Part of chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma","volume":"63","author":"Azzouzi","year":"2005","journal-title":"Ann Biol Clin"},{"issue":"2","key":"10.1016\/j.idh.2018.10.004_bib19","first-page":"228","article-title":"Chronic infection & coronary artery disease with special reference to Chlamydia pneumoniae","volume":"135","author":"Padmavati","year":"2012","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.idh.2018.10.004_bib20","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.1086\/315623","article-title":"Chlamydia pneumoniae and atherosclerosis risk in populations: the role of seroepidemiology","volume":"181","author":"Siscovick","year":"2000","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.idh.2018.10.004_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.15.1.1-20.2002","article-title":"Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies","volume":"15","author":"Boman","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.idh.2018.10.004_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jvs.2004.04.027","article-title":"Genomic, serologic, and clinical case-control study of Chlamydia pneumoniae and peripheral artery occlusive disease","volume":"40","author":"Linares-Plomino","year":"2004","journal-title":"J Vasc Surg"},{"issue":"4","key":"10.1016\/j.idh.2018.10.004_bib23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jobm.200410501","article-title":"A positive association of peripheral arterial occlusive diseases (PAD) Chlamydophila (chlamydia) pneumoniae","volume":"45","author":"Fernandez","year":"2005","journal-title":"J Basic Microbiol"},{"issue":"3","key":"10.1016\/j.idh.2018.10.004_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.STR.0000202624.89869.e9","article-title":"Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke","volume":"37","author":"Elkind","year":"2006","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.idh.2018.10.004_bib25","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.05.016","article-title":"Novel inflammatory biomarkers and their correlation to chlamydia pneumonia titres in acute ischemic stroke","volume":"l23","author":"Srivastava","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.idh.2018.10.004_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2003.10.017","article-title":"Association of antibodies to chlamydial lipopolysaccharide with endovascular presence of Chlamydophila pneumoniae in carotid artery disease","volume":"173","author":"Tiran","year":"2004","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.idh.2018.10.004_bib27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1128\/cdli.3.6.706-709.1996","article-title":"Limits of microimmuofluorescence test and advantges of immunoblotting in the diagnisis of chlamydiosis","volume":"6","author":"Biendo","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.idh.2018.10.004_bib28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1099\/jmm.0.020362-0","article-title":"Serological diagnosis of Chlamydia pneumoniae infection and perspectives","volume":"59","author":"Villegas","year":"2010","journal-title":"J Med Microb"},{"issue":"5","key":"10.1016\/j.idh.2018.10.004_bib29","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/JCM.39.5.1859-1864.2001","article-title":"Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals","volume":"39","author":"Schumakher","year":"2001","journal-title":"J Clin Mirobiol"},{"issue":"4","key":"10.1016\/j.idh.2018.10.004_bib30","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/322632","article-title":"Standardizing Chlamydia pneumoniae assays: recommendations from the centers for disease control and prevention (USA) and the laboratory centre for disease control (Canada)","volume":"33","author":"Dowell","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idh.2018.10.004_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0213-005X(08)75279-0","article-title":"Chlamydophila pneumonie: from its proteomics to arteriosclerosis","volume":"26","author":"Villegas","year":"2008","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"issue":"3","key":"10.1016\/j.idh.2018.10.004_bib32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.167.3.817","article-title":"High-resolution of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis","volume":"167","author":"Stephens","year":"1988","journal-title":"J Exp Med"}],"container-title":["Infection, Disease & Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468045118301469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468045118301469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:12:14Z","timestamp":1762834334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468045118301469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2468045118301469"],"URL":"https:\/\/doi.org\/10.1016\/j.idh.2018.10.004","relation":{},"ISSN":["2468-0451"],"issn-type":[{"value":"2468-0451","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chlamydia pneumoniae sero-prevalence in Moroccan patients with cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Infection, Disease & Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idh.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Australasian College for Infection Prevention and Control. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}